Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"

Circulation. 2018 Feb 27;137(9):988. doi: 10.1161/CIRCULATIONAHA.117.031407.

Authors

He Jin-Shan¹, Li Xue-Bin¹

Affiliation

¹ Department of Cardiology, Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Peking University People's Hospital, Beijing, China.

PMID: 29483179
DOI: 10.1161/CIRCULATIONAHA.117.031407

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiovascular System*
Glucose
Heart Failure*
Humans
Risk
Sodium

Substances

Sodium
Glucose